Benchmark Holdings puts itself up for sale, shares jump

22nd Jan 2024 09:33

(Sharecast News) - Shares in Benchmark Holdings jumped on Monday after the UK-listed aquaculture services group kickstarted a formal sales process

Read more

Benchmark confident after reporting year of decent growth

29th Nov 2023 09:49

(Sharecast News) - Aquaculture biotechnology company Benchmark reported a 7% increase in revenue from continuing operations in its full-year results on Wednesday, to £169.5m.

Read more

Benchmark gets two new salmon broodstock licences in Norway

10th Oct 2023 11:32

(Sharecast News) - Aquaculture biotechnology specialist Benchmark Holdings announced on Tuesday that it has obtained two new salmon broodstock licences from the Directory of Fisheries in Norway.

Read more

Benchmark confident in full-year amid mixed trading

24th Aug 2023 08:17

(Sharecast News) - Aquaculture biotechnology company Benchmark said in an update on Thursday that its third-quarter revenue came in at 6% below the prior year's figure.

Read more

Benchmark reports strong growth in first half

23rd May 2023 14:40

(Sharecast News) - Aquaculture biotechnology company Benchmark reported a 25% rise in revenues in its first half on Tuesday, to £98.9m.

Read more

Benchmark makes strong start in first quarter

28th Feb 2023 16:28

(Sharecast News) - Aquaculture specialist Benchmark announced a strong start to the year on Tuesday, with growth reported in all of its business areas in the first quarter.

Read more

Benchmark buys remaining interest in Iceland salmon egg subsidiary

17th Feb 2023 09:36

(Sharecast News) - Aquaculture biotechnology specialist Benchmark has acquired the remaining 10.52% minority interest in its Benchmark Genetics Iceland subsidiary, it announced on Friday.

Read more

Revenue, earnings rise in Benchmark full-year numbers

30th Nov 2022 12:04

(Sharecast News) - Aquaculture biotechnology specialist Benchmark reported a 27% improvement in revenue in its full-year results on Wednesday, to £158.3m.

Read more

Benchmark delivers better-than-expected performance in Q4

24th Oct 2022 08:35

(Sharecast News) - Biotechnology business Benchmark said on Monday that following "strong" Q3 results and "a continued positive performance" throughout the rest of the fiscal year, it had experienced better-than-expected trading across its three business areas in Q4.

Read more

Benchmark completes new £64m senior green bond issue

16th Sep 2022 14:32

(Sharecast News) - Aquaculture biotechnology company Benchmark has successfully completed a new senior unsecured green bond issue of NOK 750m (£64m), it announced on Friday, with expected maturity on 27 September 2025.

Read more

Benchmark revenues rise in third quarter

25th Aug 2022 12:44

(Sharecast News) - Aquaculture biotechnology company Benchmark reported a 28% improvement in third-quarter revenues on Thursday, to £36.3m.

Read more

Aquaculture firm Benchmark posts strong first half

18th May 2022 14:52

(Sharecast News) - Aquaculture biotechnology company Benchmark described an "excellent" first half performance on Wednesday, with revenues rising 33%, or 32% at constant exchange rates, to £79.2m.

Read more

Benchmark given variation to marketing authorisation in Norway

3rd May 2022 09:46

(Sharecast News) - Aquaculture biotechnology company Benchmark has been granted a variation to its marketing authorisation for 'Ectosan Vet' from the Norwegian Medicines Agency, it announced on Tuesday.

Read more

Benchmark records 'good performance' across business in Q1

22nd Feb 2022 09:23

(Sharecast News) - Aquaculture company Benchmark reported a "good performance" in all its business areas in its first quarter update on Tuesday, with group revenue up 38% year-on-year on an actual basis and at constant exchange rates.

Read more

Benchmark posts strong results as aquaculture markets recover

29th Nov 2021 10:31

(Sharecast News) - Aquaculture biotechnology company Benchmark reported "strong" full-year results on Monday, with revenue from continuing operations increasing 18% to £125.2m, or 24% at constant exchange rates.

Read more